India's largest drugmaker Sun Pharma is confident that its specialty sales business will continue its growth momentum and ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

The FDA inspected the facility in April ... to "comprehensively" assess its operations. For the US import alert to be lifted, Sun Pharma must conduct an independent, retrospective assessment ...

The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes ...

Sun Pharmaceutical Industries posted a 5.2 percent year-on-year (YoY) rise in net profit for the third quarter of Financial ...

Sun Pharmaceutical Industries began with just 5 products to treat psychiatry ailments in 1983. Sales were initially limited to 2 states – West Bengal and Bihar. Sales were rolled out nat..

Shares of Sun Pharma rose today after falling for five consecutive sessions as the healthcare firm said the company would not revise its revenue guidance downwards for the current financial year ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, reported a better-than-expected 5.2% rise in ...

Sun Pharmaceutical Industries, a leading Indian pharma giant with revenues of over Rs. 38,400 crore plus, has posted consolidated revenue growth of 14 per cent during the third quarter ended December ...

The Food and Drug Administration has filed a lawsuit accusing a Boca Raton pharmaceutical company ... from suppliers on the FDA’s Import Alerts list, which gives the agency authority to detain ...